(15 September 2015) TheHealthSite reports that Indian scientists have created the world’s first comprehensive open database on curcumin — the star therapeutic component of the golden Indian spice turmeric and a hot favourite with researchers across the globe — to foster innovation and generate public awareness.
Curcumin (diferuloyl methane), a hydrophobic polyphenol derived from the spice turmeric and its analogs exhibit a wide range of pharmacological activities including antimicrobial, antioxidant, anti-inflammatory, and anti-cancer activities. The Curcumin Resource Database (CRDB) is an integrated and curated repository of curcumin analogs and their molecular targets. CRDB also contains information of various international and national patents on curcumin and its analogs. Currently the database has 1,186 curcumin analogs with their 196 molecular targets curated from public domain databases and published literature in peer reviewed journals. The CRDB web portal contains user-friendly interfaces and is expected to be highly useful to the researchers working on structure/ligand based molecular design of curcumin analogs.
The Curcumin Resource Database (CRDB) is a collaborative effort of the Indian Institute of Technology-Guwahati (IIT-G), Institute of Advanced Study on Science and Technology (IASST) and the Central University of South Bihar (CUSB), Patna.
Visit the CRDB website.
